C12Y 301/30002
Serratia marcescens nuclease
Official title: Serratia marcescens nuclease (3.1.30.2)
C12Y301/30002 (Serratia marcescens nuclease) appears on 9 US grants and 21 published applications in this corpus.
Search patents in C12Y- Granted patents
- 9
- Published applications
- 21
- Assignees
- 16
- Inventors
- 55
- Latest grant
- 28 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2016 | 0 | 3 |
| 2017 | 0 | 2 |
| 2018 | 0 | 1 |
| 2019 | 1 | 0 |
| 2020 | 2 | 0 |
| 2021 | 1 | 4 |
| 2022 | 0 | 0 |
| 2023 | 1 | 4 |
| 2024 | 1 | 2 |
| 2025 | 2 | 2 |
| 2026 | 1 | 3 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Acellular dermal matrix for skin and surgical reconstruction and methods of making same28 Jul 2026US 12,691,202 B1Humabiologics, Inc.
- Double tagged Serratia Marcescens nuclease7 Oct 2025US 12,435,319 B2AbClonal Science, Inc.
- Method for purifying antibody or antibody-like molecule18 Mar 2025US 12,252,510 B2Kaneka Corporation
- Method for purifying exosomes from a cell culture medium2 Jul 2024US 12,025,592 B1Nexcalibur Therapeutics, Corp.
- Nucleases and methods for making and using them25 Apr 2023US 11,634,698 B2BASF SE
- Methods of Isolating Poxviruses from Avian Cell Cultures27 Aug 2026US 2026/0248906 A1Bavarian Nordic A/S
- Engineered nuclease with high salt tolerance30 Jul 2026US 2026/0218142 A1Wuxi Biologics Ireland Limited
- Double Tagged Serratia Marcescens Nuclease2 Apr 2026US 2026/0092265 A1AbClonal Science, Inc.
- A system for an ocular gene therapy and a process for preparing thereof25 Sep 2025US 2025/0295808 A1Indian Institute of Technology Kanpur
- Methods of purifying an enveloped virus17 Jul 2025US 2025/0230419 A1CSL Behring GmbH
Most cited
By later US patents
- Method of treating a fabric4US 10,513,671 B2The Procter & Gamble Company · 2019
- Thermolabile Serratia Marcescens nuclease4US 10,920,202 B1AbClonal Science, Inc. · 2021
- Fabric softening compositions comprising an esterquat and bacterial nuclease enzyme2US 10,723,976 B2The Procter & Gamble Company · 2020
- Compositions and methods for the detection of nucleic acids1US 10,876,149 B2Prominex, Inc. · 2020